Exact comparisons of means and within-subject variances in 2 x 2 crossover trials

Drug Information Journal

Volumn 33, Issue 2, 1999, Pages 455-469

  Guilbaud, Olivier ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Bioequivalence; Intersection union tests; Multiple comparisons; Stepwise confidence intervals; Stepwise tests

Indexed keywords

PENTOBARBITAL; WATER;

BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELIXIR; FRUIT JUICE; HUMAN; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0033067447     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159903300217     Document Type: Review

References (27)

1. Jones B, Kenward MG. Design and Analysis of Cross-over Trials. London: Chapman and Hall; 1989.
2. Senn S. Cross-over Trials in Clinical Research. New York: John Wiley and Sons; 1993.
3. Ratkowsky DA, Evans MA, Alldredge JR. Cross-over Experiments: Design, Analysis and Application. New York: Marcel Dekker; 1993.
4. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker; 1992.
5. Anderson S, Hauck WW. Consideration of individual bioequivalence. J Pharmaco Biopharm. 1990; 18:259-273.
6. Hauck WW, Anderson S. Types of bioequivalence and related statistical considerations. Int J Clin Pharmaco Ther Toxicol. 1992;30:181-187.
7. Anderson S. Individual bioequivalence: a problem of switchability. Biopharmaceutical Report from the Biopharmaceutical Section of the American Statistical Association. 1993;2:1-11.
8. Chow SC, Liu JP. Recent statistical developments in bioequivalence trials - a review of the FDA guidance. Drug Inf J. 1994;28:851-864.
9. Guilbaud O. Exact inference about the within-subject variability in 2 × 2 crossover trials. J Am Stat Assoc. 1993;88:939-946.
10. SAS Institute Inc. SAS/STAT User's Guide. Version 6, 4th ed. Cary, NC; 1989.
11. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley and Sons; 1986.
12. Lehmann EL. Testing Statistical Hypotheses. 2nd ed. New York: John Wiley and Sons; 1986.
13. Bofinger E. Expanded confidence intervals, one-sided tests, and equivalence testing. J Biopharma Stat. 1992;2:181-188.
14. Brown LD, Casella G, Hwang JTG. Optimal confidence sets, bioequivalence, and the Limaçon of Pascal. J Am Stat Assoc. 1995;90:880-889.
15. Hochberg Y, Tamhane AC. Multiple Comparison Procedures. New York: John Wiley and Sons; 1987.
16. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat Sci. 1996;11:283-319.
17. Brown LD, Hwang JTG, Munk A. An unbiased test for the bioequivalence problem. Ann Stat. 1997;25: 2345-2367.
18. Wang W. Optimal unbiased tests for equivalence in intrasubject variability. J Am Stat Assoc. 1997;92: 1163-1170.
19. Schuirmann DJ. On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval (Abstract). Biometrics. 1981;37: 617.
20. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmaco Biopharma. 1987;15:657-680.
21. Westlake WJ. Bioequivalence testing - a need to rethink (Reader Reaction Response). Biometrics. 1981;37:591-593.
22. Berger RL. Multiparameter hypothesis testing and acceptance sampling. Technometrics. 1982;24:295-300.
23. Liu JP, Chow SC. On the assessment of variability in bioavailability/bioequivalence studies. Comm Stat-Theory Meth. 1992;21:2591-2607.
24. Snikeris F, Tingey HB. A two-step method for assessing bioequivalence. Drug Inf J. 1994;28:709-722.
25. Hsu JC, Berger RL. Stepwise confidence intervals without multiplicity adjustment for dose response, multiple endpoints, and toxicity studies. Technical Report 610, Department of Statistics, Ohio State University; 1997.
26. Aitchison. Confidence-region tests. J Roy Stat Soc, B. 1964;26:462-476.
27. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics. 1972;28:577-584.